Target intelligence / Profile preview

Chlorine oxide radical (ClO•) (ClO•)

Target
ClO•
Molecular classification
Reactive chlorine species (RCS), Free radical, Reactive oxygen species (ROS) component
01

Overview

The chlorine oxide radical (ClO•), also known as the chlorine monoxide radical, is a highly reactive and short-lived chemical species belonging to the reactive chlorine species (RCS) family [1, 14, 21]. While extensively characterized in atmospheric chemistry and advanced oxidation processes for water treatment, its biological significance arises from its role as a mediator of oxidative stress and immune-mediated host defense [4, 12, 23]. In the human body, ClO• is primarily generated as a downstream byproduct of the enzyme myeloperoxidase (MPO), which produces hypochlorous acid (HOCl) that can subsequently react with other radicals or undergo photolysis to yield ClO• [12, 14]. As a powerful one-electron oxidant, the radical assists in the inactivation of pathogens by damaging their cell walls and genetic material; however, its persistent or excessive production leads to the non-selective oxidation of host proteins, lipids, and DNA [4, 15, 23]. This collateral oxidative damage is a key factor in the pathogenesis of chronic inflammatory conditions, such as atherosclerosis and neurodegenerative disorders [4, 23]. From a pharmacological perspective, ClO• is not considered a traditional therapeutic target (e.g., a receptor or enzyme), but it is a target for scavenging by antioxidants like N-acetylcysteine and for prevention through the therapeutic inhibition of MPO [14, 21].

Other names
Chlorine monoxide radicalHypochlorite radicalClOClO.ClO radical
02

Mechanism of action

Neutralization via radical scavenging and one-electron reduction; inhibition of enzymatic production through myeloperoxidase (MPO) antagonism.

03

Biological functions

Oxidative stress inductionPathogen inactivationBiomolecule oxidationInnate immune defense
04

Disease associations

InflammationTissue damageAtherosclerosisNeurodegenerative diseaseChronic obstructive pulmonary disease (COPD)
05

Safety considerations

Non-specific cytotoxicityRespiratory and mucosal irritationPotential for toxic disinfection byproduct (DBP) formationPro-oxidant mutagenicity
06

Interacting drugs

Ascorbic acid

5 more in the full profile.

07

Biomarkers

3-chlorotyrosine5-chlorocytosineChlorinated lipids

Beyond the preview

Go deeper on Chlorine oxide radical (ClO•) (ClO•).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chlorine oxide radical (ClO•) (ClO•).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call